Lunai Bioworks Inc. (LNAI)
NASDAQ
Closed
Oct 28, 2026
Day's Range
0.202052 wk Range
0.2020Overview - LNAI - Lunai Bioworks Inc.
Key Statistics
Valuation
Enterprise Value
1.25M
P/E (Trailing)
-0.0034
Price / Sales (TTM)
25.69
Price / Book
-0.09
EV / EBITDA
-0.16
Profitability
Gross Margin
100.00%
Profit Margin
0.00%
Operating Margin
-6,888.56%
Return on Assets
-54.10%
Return on Equity
833.76%
Ownership
Shares Outstanding
4.47M
Float
3.09M
Short % of Shares Outstanding
3.75%
Held by Insiders
37.48%
Held by Institutions
3.92%
Price stats
Beta
0.35
50-Day Avg
1.76
200-Day Avg
3.06
Dividends
Payout Ratio
0.00%
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LNAI - Lunai Bioworks Inc.
Peers - LNAI - Lunai Bioworks Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- LNAINASDAQLunai Bioworks Inc.1.33MMarket Cap-2747.46%52-week change-0.00P/E (Trailing)0.00%Profit Margin
- ARGXNASDAQArgenx SE54.66BMarket Cap+4.54%52-week change30.26P/E (Trailing)31.73%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.97BMarket Cap-110.32%52-week change37.78P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.32BMarket Cap+5.36%52-week change-18.03P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.71BMarket Cap+3.36%52-week change151.22P/E (Trailing)2.14%Profit Margin
Profile Summary - LNAI - Lunai Bioworks Inc.
About
Lunai Bioworks Inc. is a pre-clinical biotechnology company focused on developing medicines, diagnostics, and biodefense solutions. The company works across cancer, infectious disease, and precision medicine through genetically modified cell and immune-therapy platforms, including allogeneic dendritic cell vaccine…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
